Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal
LifeMD, Inc. (NASDAQ: LFMD) is a leading digital health company that provides direct-to-consumer telemedicine services across the United States. Founded in 1994 as Immudyne, Inc., and later renamed Conversion Labs, Inc. in 2018, the company rebranded to LifeMD in February 2021. Headquartered in New York City, LifeMD connects individuals with licensed medical professionals for a wide range of health needs, including primary care, men's sexual health, dermatology, hair restoration, and allergy/immunology. Its portfolio of specialized virtual care platforms includes ShapiroMD for hair restoration, RexMD for men's health, LifeMD Primary Care for subscription-based virtual primary care, Cleared for allergic and asthmatic conditions, and Nava MD for women's skincare and tele-dermatology. The company also offers PDFSimpli, a cloud-based SaaS platform for PDF document management. LifeMD generates revenue through direct-to-consumer e-commerce channels and partnerships, with a focus on subscription-based models. As of the latest data, LifeMD has a market capitalization of approximately $170 million and employs around 347 full-time employees. The company is led by co-founder and CEO Justin Schreiber. Despite significant revenue growth (reaching $153 million in 2024), LifeMD has reported negative net income and operating cash flow, indicating ongoing investments in scaling its operations. Key financial ratios show a high gross profit margin of 85.9%, but also negative profit margins and returns on assets and equity, reflecting current unprofitability. LifeMD competes in the rapidly evolving telehealth industry, aiming to provide cost-effective, convenient healthcare solutions. Recent news highlights its acquisition of women's health assets from Optimal Human Health MD to expand into that market. The company's long-term success depends on achieving profitability while managing competition and regulatory changes in the healthcare sector.
